Skip to content

Clinical study on the treatment of obese people based on Xiaoyu Reducing weight formula combined with umbilical therapy formula

Clinical study on the treatment of obese people based on Xiaoyu Reducing weight formula combined with umbilical therapy formula

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090686
Enrollment
Unknown
Registered
2024-10-11
Start date
2023-03-23
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity

Interventions

Intervention group:Xiaoyu weight reduction prescription combined with umbilical therapy prescription

Sponsors

Guang’anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1: In line with the diagnostic criteria of obesity,The type of TCM syndrome is stomach heat-dampness obstruction 2: Patients ranged in age from 18 to 65 years 3: Those who are generally in good condition and voluntarily and actively cooperate with relevant treatment in this study 4: Signed informed consent

Exclusion criteria

Exclusion criteria: 1: Patients with secondary obesity, such as those suffering from neurological diseases (hypothalamic diseases, pituitary tumors, etc.), endocrine diseases (hypothyroidism, hyperadrenocorticosis, diabetes, etc.), and obesity caused by drug-related factors (long-term heavy administration or use of adrenocorticosteroids, use of contraceptives, etc.); 2: Patients 65 years old 3: Severely malnourished, generally in poor condition, unable to cooperate with examination and treatment 4: Patients with a series of serious primary diseases such as heart, liver, kidney, hematopoietic coagulation system, endocrine system and mental illness 5: Obese patients who are currently receiving, or have recently received, other drugs, hypoglycemic drugs or non-drug therapy, or are participating in other clinical trials 6: Women who are pregnant, preparing to become pregnant or breastfeeding 7: People who are allergic to relevant Chinese medicine ingredients and allergic constitution 8: Patients with uncontrolled or controlled blood pressure, systolic blood pressure =160mmHg or/and diastolic blood pressure =100mmHg, the dosage and type of antihypertensive drugs taken cannot remain stable 9: According to the judgment of the researchers, other diseases or conditions that reduce the possibility of enrollment or complicate enrollment, such as frequent changes in the working environment, unstable living environment and other conditions that are easy to cause the loss of follow-up

Design outcomes

Primary

MeasureTime frame
body mass index;

Secondary

MeasureTime frame
excrement;Hip circumference;Obesity degree;Percentage of fat;TCM syndrome integral;

Countries

China

Contacts

Public ContactMin Li

Guang’anmen Hospital, China Academy of Chinese Medical Sciences

495134041@qq.com+86 132 6102 9206

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026